A detailed history of Ophir Asset Management Pty LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Ophir Asset Management Pty LTD holds 763,074 shares of ADMA stock, worth $13.3 Million. This represents 2.58% of its overall portfolio holdings.

Number of Shares
763,074
Previous 1,831,330 58.33%
Holding current value
$13.3 Million
Previous $20.5 Million 25.5%
% of portfolio
2.58%
Previous 3.8%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $12 Million - $21.4 Million
-1,068,256 Reduced 58.33%
763,074 $15.3 Million
Q2 2024

Aug 14, 2024

SELL
$5.98 - $11.18 $9.56 Million - $17.9 Million
-1,597,987 Reduced 46.6%
1,831,330 $20.5 Million
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $15.1 Million - $23.1 Million
3,429,317 New
3,429,317 $22.6 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Ophir Asset Management Pty LTD Portfolio

Follow Ophir Asset Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ophir Asset Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ophir Asset Management Pty LTD with notifications on news.